Medical Record Review
Review of the diagnosis, imaging, laboratory studies, treatment history, current medications and relevant physician reports.
Patient information for residents of Mexico
EspañolCELLMEX provides local patients with access to physician-led evaluation, scientific review, personalised treatment planning and coordinated follow-up care. Every patient is assessed individually before any treatment is considered.
Regenerative medicine includes a broad group of biological technologies intended to study, support or influence tissue repair, immune signalling and cellular function.
These technologies may include mesenchymal stromal cells, extracellular vesicles, secretome-derived preparations and other laboratory-developed biological platforms.
The suitability of any intervention depends on the patient's diagnosis, medical history, current medications, previous treatments, disease severity and the scientific evidence available for the proposed use.
CELLMEX does not treat every enquiry as an automatic treatment candidate. The first step is a structured medical and scientific review.
Local patients benefit from easier access to consultation, medical-record review, in-person evaluation and post-treatment monitoring.
Review of the diagnosis, imaging, laboratory studies, treatment history, current medications and relevant physician reports.
A structured consultation to understand the patient's condition, symptoms, objectives, treatment history and potential contraindications.
Determination of whether a patient may be medically suitable for further evaluation, supportive regenerative care or an alternative treatment pathway.
Where medically appropriate, the clinical team prepares a treatment plan based on diagnosis, objectives, route of administration, monitoring and follow-up requirements.
Local scheduling, preparation instructions, physician attendance, clinical documentation and treatment-day coordination.
Post-treatment review, symptom tracking, adverse-event reporting, laboratory follow-up and coordination with the patient's regular physician when appropriate.
The following categories may be reviewed by the clinical team. Listing a condition does not imply that a specific regenerative treatment is approved, proven or appropriate for every patient.
Evaluation may include joint degeneration, cartilage injury, tendon disorders, sports injuries and selected chronic musculoskeletal conditions.
Selected patients may be reviewed where immunomodulatory or anti-inflammatory biological mechanisms are scientifically relevant.
Certain neurological conditions may be considered for records review, particularly when investigational biological approaches are being evaluated.
Evaluation may include selected metabolic, vascular or tissue-repair conditions where biological support strategies are under study.
Selected skin, scalp and tissue-quality concerns may be evaluated where local regenerative or cell-free biological technologies are relevant.
Patients with uncommon or complex diagnoses may submit records for scientific and medical review, although treatment may not be available.
The patient pathway is designed to protect patient safety and ensure that treatment decisions are based on appropriate clinical information.
The patient provides contact details, diagnosis, principal symptoms and the reason for seeking an evaluation.
Relevant records, imaging, laboratory results and prior treatment information are submitted for review.
A physician evaluates the information and determines whether an in-person or remote consultation is appropriate.
The patient receives an explanation of suitability, limitations, possible alternatives and whether further evaluation is recommended.
Accepted patients receive preparation instructions, clinical coordination and a defined follow-up plan.
Provide basic information about your condition. A patient coordinator can then explain the records required for medical review.
+52 (322) 308 0021
patients@cellmex.com
Monday–Friday
9:00 a.m.–5:00 p.m.
Mexico
Marina Vallarta, Pto Vallarta Jalisco